[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-369713-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-369713-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","oncolytic-viral-therapy-as-a-novel-potential-solution-for-treatment-of-pancreatic-cancer","Oncolytic viral therapy as a novel potential solution for treatment of pancreatic cancer","","Pancreatic cancer remains highly lethal, with limited improvement in survival despite advances in chemotherapy, targeted therapies, and radiation. Clinical outcomes have not substantially changed 5-year survival, and many patients still experience relapse and progression. Rapid discoveries of pancreatic cancer genetics and molecular mechanisms are enabling new opportunities for targeted approaches, including oncolytic viral therapy. The narrative review evaluates evidence supporting oncolytic viruses and their potential applications as a future alternative treatment, detailing their therapeutic relevance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/oncolytic-viral-therapy-as-a-novel-potential-solution-for-treatment-of-pancreatic-cancer/369713/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/oncolytic-viral-therapy-as-a-novel-potential-solution-for-treatment-of-pancreatic-cancer/369713.png","ImageObject",300,407,{"name":42,"@type":43},"Pentious","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why is pancreatic cancer difficult to treat and improve survival rates?","Question",{"text":63,"@type":64},"Pancreatic cancer has a highly fatal course with minimal gains in survival over time. Relapse is common and the disease shows limited response despite current chemotherapy, targeted treatments, and radiation therapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What is oncolytic viral therapy and how does it work in pancreatic cancer?",{"text":68,"@type":64},"Oncolytic viral therapy uses genetically altered viruses that preferentially attach to and invade cancer cells. Viral replication makes tumor cells more detectable, enabling immune responses that contribute to tumor cell elimination.",{"name":70,"@type":61,"acceptedAnswer":71},"What does the narrative review cover regarding pancreatic cancer treatment and research directions?",{"text":72,"@type":64},"The review discusses pancreatic cancer mechanisms and progression risk factors, outlines current applicable treatments such as surgery, chemotherapy, radiotherapy, and immunotherapy, and highlights future promising therapeutic targets, emphasizing oncolytic viruses as potential future options.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},369713,1790520409,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1374404730887,"https://ap-avatar.wpscdn.com/davatar_6f874abed73319feea01a86fa6f0fab8","Gastroenterology and Hepatology From Bed to Bench.  \n2025 RIGLD, Research Institute for Gastroenterology and Liver Diseases   \nREVIEW ARTICLE  \np-ISSN: 2008-2258 e-ISSN: 2008-4234  \nOncolytic viral therapy as a novel potential solution for treatment of pancreatic cancer  \nPiruz Shadbash1,2, Seyed Masoud Hosseini2, Sahel Abyar1,2, Shahrzad Shoraka2, Amir Ghaemi3, Nosratollah Naderi4, Seyed Reza Mohebbi4  \n1Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n2Department of Microbiology and Microbial Biotechnology, Faculty of Life Sciences and Biotechnology, Shahid Beheshti University, Tehran, Iran  \n3Department of Virology, Pasteur Institute of Iran, Tehran, Iran  \n4Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \nABSTRACT  \nPancreatic cancer (PC) remains one of the most formidable malignancies, with survival rates showing minimal improvement over the years despite progress in chemotherapy, targeted treatments, and radiation therapy. The development of targeted agents and chemotherapy for cancer treatment has only moderately influenced clinical results and has not significantly altered 5-year survival rates. However, with the rapid discovery of the genetic and molecular functions underlying PC, new opportunities for targeted therapies are emerging. One promising approach is oncolytic viral therapy, which has shown potential as a targeted agent for the treatment of pancreatic cancer. Based on the available evidence, oncolytic viral therapy appears to be a viable treatment option for pancreatic cancer. In the present narrative review, we explore oncolytic viruses in detail, and their potential applications in cancer therapy as a future alternative treatment are investigated.  \nKeywords: Pancreatic cancer, Oncolytic viral treatment, Therapeutic Targets, Chemoresistance, Immunotherapy.  \n(Please cite as: Shadbash P, Hosseini SM, Abyar S, Shoraka S, Ghaemi A, Naderi N, Mohebbi SR. Oncolytic viral therapy as a novel potential solution for treatment of pancreatic cancer: Oncolytic viruses and pancreatic cancer. Gastroenterol Hepatol Bed Bench 2025;18(1):53-69. [https://doi.org/10.22037/ghfbb.v18i1.3066](https://doi.org/10.22037/ghfbb.v18i1.3066)).   \nIntroduction  \nThe pancreas is identified as a gland and a part of the digestive system with two different functions. It plays an important role in the endocrine system by secreting hormones such as insulin, glucagon, and somatostatin, and its function in the exocrine section is known to be producing digestive enzymes, including amylase and lipase, and alkaline fluid. The pancreas exocrine section includes two types of cells identified as acinar and ductal cells.  \nReceived: 14 August 2024 Accepted: 28 October 2024 Reprint or Correspondence: Seyed Reza Mohebbi, Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran.  \nE-mail: [sr.mohebbi@sbmu.ac.ir](sr.mohebbi@sbmu.ac.ir)  \n[ORCID ID:](ORCID ID: 0000-0002-7020-7889)[ 0000-0002-7020-7889](ORCID ID: 0000-0002-7020-7889)  \nAcinar cells are recognized to be involved in storing and releasing both active enzymes (e.g., amylase, lipase) and inactive enzymes, known as zymogens, such as trypsinogen (1) .  \nAfter 40 years of cancer research, pancreatic adenocarcinoma remains a highly fatal illness that is particularly difficult to diagnose and treat. The five-year survival rate shows only a slight improvement, and almost all patients relapse and succumb to the illness (2) . It is the fourth leading cause of death from cancer in the United States, with approximately 66,440 new cases diagnosed in 2024 and 51,750 related deaths (3, 4) . Currently, combinational t","cbCailRJkFnMXrZl","https://ap.wps.com/l/cbCailRJkFnMXrZl","pdf",987146,17,"English","# Abstract\n# Introduction\n# Biology of pancreatic cancer and the factors involved in its progression","[{\"question\":\"Why is pancreatic cancer difficult to treat and improve survival rates?\",\"answer\":\"Pancreatic cancer has a highly fatal course with minimal gains in survival over time. Relapse is common and the disease shows limited response despite current chemotherapy, targeted treatments, and radiation therapy.\"},{\"question\":\"What is oncolytic viral therapy and how does it work in pancreatic cancer?\",\"answer\":\"Oncolytic viral therapy uses genetically altered viruses that preferentially attach to and invade cancer cells. Viral replication makes tumor cells more detectable, enabling immune responses that contribute to tumor cell elimination.\"},{\"question\":\"What does the narrative review cover regarding pancreatic cancer treatment and research directions?\",\"answer\":\"The review discusses pancreatic cancer mechanisms and progression risk factors, outlines current applicable treatments such as surgery, chemotherapy, radiotherapy, and immunotherapy, and highlights future promising therapeutic targets, emphasizing oncolytic viruses as potential future options.\"}]","Oncolytic viral therapy as a novel potential solution for treatment of pancreatic cancer | PDF",1790184187,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3309740916f74f2dad0fc566984a6ec3.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/aebdb414109a529b1089083f40afa294.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e42db4ed872227c9fee9e7390084ebc3.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cb6c3bdc1435350e3a64a1f3966bc0fb.webp",980,1268]